Skip to main content
SpringerLink
Log in

Teoria infettiva e agenti patogeni

  • Chapter
Aterosclerosi

  • 351 Accesses

Riassunto

Molti studi pubblicati negli ultimi dieci anni hanno analizzato la possibile associazione tra diverse infezioni virali o batteriche e aterosclerosi. Si è supposto che queste infezioni possano favorire la formazione o le complicanze delle placche aterosclerotiche. Non è ancora stato raggiunto un consenso sui possibili effetti aterogenetici degli agenti microbici analizzati e il meccanismo patogenetico rimane ancora non completamente chiarito.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 32.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Nieto FJ (1998) Infections and atherosclerosis. New clues from an old hypothesis? Am J Epidemiol 148:937–948

    PubMed  CAS  Google Scholar 

  2. Fabricant CG, Fabricant J, Litrenta MM et al (1978) Virus-induced atherosclerosis. J Exp Med 148(1):335–340

    Article  PubMed  CAS  Google Scholar 

  3. Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983–986

    Article  PubMed  CAS  Google Scholar 

  4. Boman J, Hammerschlag MR (2002) Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment strategies. Clin Microb Rev 15:1–20

    Article  CAS  Google Scholar 

  5. Mendall M, Goggin PM, Molineaux N et al (1994) Relation of Helicobacter Pylori infection and coronary heart disease. Br Heart J 71:437–439

    Article  PubMed  CAS  Google Scholar 

  6. Gupta S, Leatham EW, Carrington D et al (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azythromycin in male survivors of myocardial infarction. Circulation 96:404–407

    PubMed  CAS  Google Scholar 

  7. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE (2001) Detection of Helicobacter Pylori in human carotid atherosclerotic plaques. Stroke 32:385–391

    PubMed  CAS  Google Scholar 

  8. Farsak B, Yildirir A, Akyon Y et al (2000) Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 38:4408–4411

    PubMed  CAS  Google Scholar 

  9. Anderson JL (2005) Infection, Antibiotics and atherothrombosis — end of the road or new beginning? N Engl J Med 352:1706–1709

    Article  PubMed  CAS  Google Scholar 

  10. Dunne MW (2000) Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial. J Infect Dis 181 Suppl 3:S572–857

    Article  Google Scholar 

  11. Cercek B, Shah PK, Noc M et al (2003) Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 361(9360):809–813

    Article  PubMed  CAS  Google Scholar 

  12. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181:S402–S410

    Article  PubMed  CAS  Google Scholar 

  13. Ray KK, Cannon CP, Cairns R et al (2005) Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46(8):1417–2414

    Article  PubMed  CAS  Google Scholar 

  14. Gieffers J, Fullgraf H, Jahn J (2001) Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103:351–356

    PubMed  CAS  Google Scholar 

  15. Epstein SE, Zhu J, Burnett MS et al (2000) Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 20:1417–1420

    PubMed  CAS  Google Scholar 

  16. Xu Q, Dietrich H, Steiner HJ et al (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12:789–799

    PubMed  CAS  Google Scholar 

  17. Mocarski ES, Kemble GW (1996) Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 39:320–330

    PubMed  Google Scholar 

  18. Mayr M, Metzler B, Kiechl S et al (1999) Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99(12):1560–1566

    PubMed  CAS  Google Scholar 

  19. Friedman HM, Macarak EJ, MacGregor RR et al (1981) Virus infection of endothelial cells. J Infect Dis 143:266–273

    PubMed  CAS  Google Scholar 

  20. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M (1994) Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 6:313–319

    Article  Google Scholar 

  21. Van Dorp WT, Jonges E, Bruggeman CA et al (1987) Direct induction of MHC class I, but not class II, expression on endothelial cells by Cytomegalovirus infection. Thromb Res 47:69–75

    Article  Google Scholar 

  22. Datta SK, Tumilowicz JJ, Trentin JJ (1993) Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis. Viral Immunol 6:153–160

    Article  PubMed  CAS  Google Scholar 

  23. Key NS, Bach, RR, Vercellotti GM, Moldow CF (1993) Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest 68:645–651

    PubMed  CAS  Google Scholar 

  24. Waldman WJ, Adams PW, Orosz CG, Sendmak DD (1992) T lymphocyte activation by Cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 54:887–896

    Article  PubMed  CAS  Google Scholar 

  25. Campbell LA, Kuo CC (2003) Chlamydia pneumoniae and atherosclerosis. Seminars in Respiratory Infections 18:48–54

    Article  PubMed  Google Scholar 

  26. Wyplosz B, Capron L (2004) Infectious features of atherosclerosis. Med Sci (Paris) 20:169–174

    Google Scholar 

  27. Epstein SE, Speir E, Zhou YF, Guetta E (1996) The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 348:S13–S17

    Article  PubMed  CAS  Google Scholar 

  28. Speir E, Modali R, Huang ES et al (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394

    Article  PubMed  CAS  Google Scholar 

  29. Petrie BL, Adam E, Melnick JL (1988) Association of herpesvirus/cytomegalovirus infections with human atherosclerosis. Prog Med Virol 35:21–42

    PubMed  CAS  Google Scholar 

  30. Hwang CBC, Shillitoe EJ (1990) DNA sequence of mutations induced in cells by herpes simplex virus type-1. Virology 178:180–188

    Article  PubMed  CAS  Google Scholar 

  31. Epstein SE, Zhou YF, Zhu J (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:e20–e28

    PubMed  CAS  Google Scholar 

  32. Balish MF, Krause DC (2002) Cytadherence and the cytoskeleton. In: Razin S, Herrman R (eds) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers, London pp 491–518

    Chapter  Google Scholar 

  33. Maraha B, van Der Zee A, Bergmans AM et al (2000) Is Mycoplasma pneumoniae associated with vascular disease? J Clin Microbiol 38:935–936

    PubMed  CAS  Google Scholar 

  34. Zhu J, Quyyumi AA, Norman JE et al (2000) Total pathogen burden contributes incrementally to coronary artery disease risk and to C-reactive protein levels. Am J Cardiol 85:140–146

    Article  PubMed  CAS  Google Scholar 

  35. Zhu J, Nieto EJ, Horne BD et al (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45–51

    PubMed  CAS  Google Scholar 

  36. Rupprecht HJ, Blankenberg S, Bickel C et al (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25–31

    Article  PubMed  CAS  Google Scholar 

  37. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al (2002) Impact of Infectious Burden on progression of carotid atherosclerosis. Stroke 33:2581–2586

    Article  PubMed  CAS  Google Scholar 

  38. Zhu J, Shearer GM, Norman JE et al (2000) Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation 102(20):2491–2496

    PubMed  CAS  Google Scholar 

  39. Howell T, Ridker P, Ajani U (2001) Periodontal disease and risk of subsequent cardiovascular disease in U.S._male physicians. J Am Coll Cardiol 37:445–471

    Article  PubMed  CAS  Google Scholar 

  40. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA (2002) Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 81:186–191

    Article  PubMed  CAS  Google Scholar 

  41. Hujoel PP, Drangsholt M, Spiekerman C, Derouen TA (2001) Examining the link between coronary heart disease and the elimination of chronic dental infections. J Am Dent Assoc 132:883–889

    PubMed  CAS  Google Scholar 

  42. Mattila KJ, Nieminen MS, Valtonen VV et al (1989) Association between dental health and acute myocardial infarction. BMJ 298:779–781

    Article  PubMed  CAS  Google Scholar 

  43. Mattila KJ, Valle MS, Nieminen MS et al (1993) Dental infections and coronary atherosclerosis. Atherosclerosis 103:205–211

    Article  PubMed  CAS  Google Scholar 

  44. Desvarieux M, Demmer RT, Rundek T et al (2003) Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 34:2120–2125

    Article  PubMed  Google Scholar 

  45. Armitage GC (2000) Periodontal infections and cardiovascular disease: how strong is the association? Oral Dis 6: 335–350

    Article  PubMed  CAS  Google Scholar 

  46. Fong IW (2002) Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc 133 suppl: 7S–13S

    PubMed  Google Scholar 

  47. Slade GD, Offenbacher S, Beck JD et al (2000) Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79: 49–57

    Article  PubMed  CAS  Google Scholar 

  48. Loos BG, Craandijk J, Hoek FJ et al (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528–1534

    Article  PubMed  CAS  Google Scholar 

  49. Guntheroth WG (1984) How important are dental procedures as a cause of infective endocarditis? Am J Cardiol 54: 797–801

    Article  PubMed  CAS  Google Scholar 

  50. Loesche WJ, Lopatin DE (2000) Interactions between periodontal disease, medical diseases and immunity in the older individual. Periodontol 16: 80–105

    Article  Google Scholar 

  51. Herzberg MC, Weyer MW (1998) Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 3: 151–160

    PubMed  CAS  Google Scholar 

  52. Ross R (1999) Atherosclerosis. An inflammatory disease. N Engl J Med 340: 115–126

    Article  PubMed  CAS  Google Scholar 

  53. Beck JD, Elter JR, Heiss G et al (2001) Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 21: 1816–1822

    Article  PubMed  CAS  Google Scholar 

  54. Ieven M, Hoymans VY (2005) Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 42:19–24

    Article  Google Scholar 

  55. Shor A, Kuo CC & Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. South African Medical Journal 82:158–161

    PubMed  CAS  Google Scholar 

  56. Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clinical Microbiol Rev 8:451–461

    CAS  Google Scholar 

  57. Ramirez JA (1996) Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis — The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Intern Med 125:979–982

    PubMed  CAS  Google Scholar 

  58. Mulhestein JB, Hammond EH, Carlquist JF et al (1996) Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555–1561

    Article  Google Scholar 

  59. Kol A, Sukhova GK, Lichtman AH et al (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98(4):300–307

    PubMed  CAS  Google Scholar 

  60. Beatty WL, Morrison RP, Byrne GI (1994) Persistent Chlamydiae: from cell culture to a paradigm for Chlamydial pathogenesis. Microbiol Rev 58:686–699

    PubMed  CAS  Google Scholar 

  61. Grayston JT, Kuo CC, Coulson AS et al (1995) Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92:3397–3400

    PubMed  CAS  Google Scholar 

  62. Johnston SC, Messina LM, Browner WS et al (2001) C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 32:2748–2752

    Article  PubMed  CAS  Google Scholar 

  63. Sessa R, Di Pietro M, Schiavoni G et al (2003) Chlamydia pneumoniae DNA in patients with symptomatic carotid artheriosclerotic disease. J Vasc Surg 37:1027–1031

    Article  PubMed  Google Scholar 

  64. Mayr M, Kiechl S, Willeit J et al (2000) Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori and Cytomegalovirus with immune reactions to Heat-Shock Proteins 60 and carotid or femoral atherosclerosis. Circulation 102:833–839

    PubMed  CAS  Google Scholar 

  65. Ciervo A, Petrucca A, Cassone A (2003) Identification and quantification of Chlamydia pneumoniae in human atherosclerotic plaques by Light-Cycler Real-time PCR. Mol Cell Probes 17:107–111

    Article  PubMed  CAS  Google Scholar 

  66. Lindholt JS, Ashton HA, Scott RA (2001) Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 34:212–215

    Article  PubMed  CAS  Google Scholar 

  67. Maraha B, den Heijer M, Kluytmans J, Peeters M (2004) Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular disease. Clin Diagn Lab Immunol 11:789–791

    PubMed  Google Scholar 

  68. Lindholt JS, Stovring J, Ostergaard L et al (2004) Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 109:2097–2102

    Article  PubMed  CAS  Google Scholar 

  69. Cheuk BL, Ting AC, Cheng SW (2005) Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in abdominal aortic aneurysm walls and its association with rupture. Eur J Vasc Endovasc Surg 29:150–155

    Article  PubMed  CAS  Google Scholar 

  70. Blasi F, Denti F, Erba M et al (1996) Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34:2766–2769

    PubMed  CAS  Google Scholar 

  71. Kuo CC, Coulson AS, Campbell LA et al (1997) Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 26:29–31

    Article  PubMed  CAS  Google Scholar 

  72. Wiesli P, Caerwenka W, Meniconi A et al (2002) Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men. A randomized, double-bind, placebo controlled trail. Circulation 105:2646–2652

    Article  PubMed  CAS  Google Scholar 

  73. Hu H, Pierce GN, Zhong G (1999) The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103:747–753

    Article  PubMed  CAS  Google Scholar 

  74. Blessing E, Lin TM, Campbell LA et al (2000) Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun 68:4765–4768

    Article  PubMed  CAS  Google Scholar 

  75. Mulhestein JB (1998) Bacterial infections and atherosclerosis. J Investig Med 46(8):396–402

    Google Scholar 

  76. Liuba P, Pesonen E, Paakkari I et al (2003) Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs. Atherosclerosis 167:215–222

    Article  PubMed  CAS  Google Scholar 

  77. Taylor-Robinson D, Thomas BJ (1998) Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol 51:793–797

    Article  PubMed  CAS  Google Scholar 

  78. Higuchi L, Ramires JAF (2002) Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Rev Inst Med Trop S Paolo 44:217–224

    Google Scholar 

  79. Higuchi ML, Reis MM, Sambiase NV et al (2003) Coinfection with Mycoplasma pneumoniae and Chlamydia Pneumoniae in ruptured plaques associated with acute myocardial infarction. Ar Bras Cardiol 81:12–22

    Google Scholar 

  80. Momiyama Y, Ohmori R, Taniguchi H (2004) Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis 176.139–144

    Article  PubMed  CAS  Google Scholar 

  81. Fabricant CG, Fabricant J (1999) Atherosclerosis induced by infection with Marek’s disease herpesvirus in chickens. Am Heart J 138:S465–S468

    Article  PubMed  CAS  Google Scholar 

  82. Grattan MT, Moreno-Cabral CE, Starnes VA et al (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261(24):3561–3566

    Article  PubMed  CAS  Google Scholar 

  83. Hendrix MGR, Salimans MM, van Bouen CP, Bruggeman CA (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136:23–28

    PubMed  CAS  Google Scholar 

  84. Bruggerman CA, Marjorie HJ, Nelissen-Vrancken G (1999) Cytomegalovirus and atherogenesis. Antiviral Res 43:135–144

    Article  Google Scholar 

  85. Streblow DN, Orloff SL, Nelson JA et al (2001) The HCMV chemokine receptor US28 is a potential target in vascular disease. Curr Drug Targets Infect Disord 1:151–158

    Article  PubMed  CAS  Google Scholar 

  86. Pryzdial EL, Wright JF (1994) Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipids. Blood 84:3749–3757

    PubMed  CAS  Google Scholar 

  87. Nieto FJ, Adam E, Sorlie P et al (1996) Cohort study of cytomegalovirus infection as a risk factor for coronary intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922–927

    PubMed  CAS  Google Scholar 

  88. Bruggerman CA (2000) Does cytomegalovirus play a role in atherosclerosis? Herpes 7:51–54

    Google Scholar 

  89. Smieja M, Gnarpe J, Lonn E et al (2003) Multiple infections and subsequent caridovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 107:251–257

    Article  PubMed  Google Scholar 

  90. Ibrahima AI, Obeid MT, Jouma MJ et al (2005) Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 32:29–32

    Article  CAS  Google Scholar 

  91. Bason C, Corrocher R, Lunaroli C et al (2003) Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in the pathogenesis of atherosclerosis. Lancet 362:1971–1977

    Article  PubMed  CAS  Google Scholar 

  92. Lunardi C, Dolcino M, Peterlana D et al (2007) Endothelial cells’ activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS ONE 2:e473

    Article  PubMed  CAS  Google Scholar 

  93. Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA (2006) Immune activation following cytomegalovirus infection: more important direct viral effects in cardiovascular disease? J Clin Virol 35:349–353

    Article  PubMed  CAS  Google Scholar 

  94. Mattila KJ, Pussinen PJ, Paju S (2005) Dental infections and cardiovascular disease. A review. J Periodontol 76:2085–2088

    Article  PubMed  Google Scholar 

  95. Meurman J, Sanz M, Janket SJ (2004) Oral health, atherosclerosis and cardiovascular disease. Crit Rev Oral Biol Med 15:403–413

    Article  PubMed  Google Scholar 

  96. Joshipura KJ, Hung HC, Rimm EB et al (2003) Periodontal disease, tooth loss and incidence of ischemic stroke. Stroke 34:47–52

    Article  PubMed  Google Scholar 

  97. Beck JD, Elter JR, Heiss G et al (2001) Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscl Thromb Vasc Biol 21:1816–1822

    Article  PubMed  CAS  Google Scholar 

  98. Angeli F, Verdecchia P, Pellegrino C et al (2003) Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension 41:488–492

    Article  PubMed  CAS  Google Scholar 

  99. Moutpoulos NM, Phoebus NM (2006) Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann NY Acad Sci 1088:251–264

    Article  CAS  Google Scholar 

  100. Beck JD, Offenbacher S (2005) Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 768:2089–2100

    Article  Google Scholar 

  101. Hujoel PP, Drangsholt M, Spiekerman C, Derouen TA (2000) Periodontal disease and coronary heart disease risk. JAMA 284:1406–1410

    Article  PubMed  CAS  Google Scholar 

  102. Scannapieco FA, Bush RB, Paju S (2003) Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease and stroke. A systematic review. Ann Periodontol 8:38–53

    Article  PubMed  Google Scholar 

  103. Choi JI, Chung SV, Kang HS et al (2004) Epitope mapping of Porphyromonas gingivalis heat-shock protein and human heat-shock protein in human atherosclerosis. J Dent Res 83:936–940

    Article  PubMed  CAS  Google Scholar 

  104. Ishihara K, Nabuchi A, Ito R et al (2004) Correlation between detection rates of periodontopathic bacterial DNA in carotid coronary stenotic artery plaque and in dental plaque samples. J Clin Microbiol 42:1313–1315

    Article  PubMed  CAS  Google Scholar 

  105. Kozarov E, Sweier D, Shelburne C et al (2006) Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect 8:687–693

    Article  PubMed  CAS  Google Scholar 

  106. Spahr A, Klein E, Khuseyinova N et al (2006) Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 166:554–559

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Giuliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Spring-Verlag Italia

About this chapter

Cite this chapter

Giuliano, A. (2010). Teoria infettiva e agenti patogeni. In: Aterosclerosi. Springer, Milano. https://doi.org/10.1007/978-88-470-1412-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1412-1_8

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1411-4

  • Online ISBN: 978-88-470-1412-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation